Luveltamab Tazevibulin (STRO-002), an Anti-Folate Receptor Alpha (folrα) Antibody Drug Conjugate (ADC), Safety and Efficacy in a Broad Distribution of FolRα Expression in Patients with Recurrent Epithelial Ovarian Cancer (OC): Update of STRO-002-GM1 Phase 1 Dose Expansion Cohort.
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要